enVVeno Medical Corporation (NVNO)

USD 2.57

(-7.89%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - 31.24 Thousand 186.55 Thousand
Cost of Revenue 546 Thousand 525 Thousand 452.9 Thousand 383.97 Thousand - -
Gross Profit -546 Thousand -525 Thousand -452.9 Thousand -383.97 Thousand 31.24 Thousand 186.55 Thousand
Operating Expenses 25.23 Million 24.93 Million 16.89 Million 9.13 Million 7.11 Million 7.72 Million
Selling, General and Administrative Expenses 11.65 Million 15.01 Million 11.16 Million 4.88 Million 4.91 Million 6.48 Million
Research and Development Expenses 13.58 Million 9.91 Million 5.72 Million 4.25 Million 2.2 Million 1.23 Million
Other Expenses - - 33.27 Thousand -215.9 Thousand - -
Cost and Expenses 25.23 Million 24.93 Million 16.89 Million 9.13 Million 7.11 Million 7.72 Million
Operating Income -25.23 Million -24.93 Million -16.89 Million -9.13 Million -7.67 Million -7.85 Million
Interest Expense - - - - - 6.86 Million
Income Tax Expense - -365 Thousand -331.4 Thousand -215.54 Thousand 863.54 Thousand 1.67 Million
Earnings before Tax -23.51 Million -24.66 Million -16.52 Million -9.13 Million -7.62 Million -13.04 Million
Net Income -23.51 Million -24.3 Million -16.19 Million -8.91 Million -7.62 Million -13.04 Million
Earnings Per Share Basic -1.91 -2.16 -1.87 -6.91 -12.10 -34.83
Earnings Per Share Diluted -1.91 -2.16 -1.87 -6.91 -12.10 -34.83
Weighted Average Shares Outstanding 12.3 Million 11.23 Million 8.67 Million 1.29 Million 630.41 Thousand 374.49 Thousand
Weighted Average Shares Outstanding (Diluted) 12.3 Million 11.23 Million 8.67 Million 1.29 Million 630.41 Thousand 374.49 Thousand
Gross Margin - - - - 1.00 1.00
EBIT Margin - - - - -212.52 -39.68
Profit Margin - - - - -244.07 -69.91
EBITDA -25.01 Million -24.5 Million -16.75 Million -8.75 Million -6.96 Million -6.04 Million
Earnings Before Tax Margin - - - - -245.67 -42.11

Income Statement Charts